Sharing Life Sciences Innovations
Strong communication in biotech is lacking
Many biotech management teams fail to reach out to investors in a clear and appealing way.
Strategic Ablynx - Sanofi collaboration for up to 8 Nanobodies in immunology and inflammation
Ablynx announced that it has entered into a research collaboration and global exclusive licensing agreement with Sanofi initially focused on developing and commercialising Nanobody®-based therapeu…
Celyad announces initiation of the SHRINK trial
SHRINK study to evaluate the synergetic effect of the concurrent administration of CYAD-01 (CAR-T NKG2D) with standard chemotherapy in patients suffering from metastatic colorectal cancer.
Breakthrough in separating left- and right-handed molecules
In a discovery with broad implications for the specialty chemicals industries like pharmaceuticals, researchers at Rice University and the California Institute of Technology have succeeded in a de…
IDO 1: a promising new target for immunotherapy
iTeos Therapeutics started in 2012 as a spin-off from the Ludwig Institute for Cancer Research (LICR), one of the top three cancer institutes in the world, and the UCL. In 2014, they licensed righ…
Immunotherapy: a paradigm shift in cancer treatment
An excerpt from the BioVox White paper on Cancer Immunotherapy.
Lars Klareskog pushes rheumatology beyond symptomatic treatment
Over the years, the perception of inflammatory diseases has changed drastically. The advent of cytokine inhibitors meant great improvement to many patients, especially those suffering from rheumat…
Reinforcing veins with computer simulations
Each year, more than two million patients worldwide undergo a procedure called coronary artery bypass grafting (CABG). CABG is used to treat blocked arteries and restore normal blood flow to the h…
Diagnosing rare genetic conditions within minutes
Moon is a new software package that, within minutes, diagnoses patients who suffer from rare diseases. All the software requires are the patient’s symptoms and sequencing data. Moon then applies a…
Sylvie Janssens in Manhattan - Belgian scientist living abroad
Sylvie Janssens lives in Manhattan, New York, where she relocated after earning her PhD in biotechnology at Ghent University. She studied biomedical sciences at Ghent University, and prior to that…
Curing all diseases in the next 20 years: the new hype amongst billionaires?
Despite the initial intent of charitable foundations to be not-for-profit, some of them tend to morph into organizations with bigger aspirations.
Investing in European biotech faced with many challenges
Investing in biotech companies is a capital-intensive and risky business, and it’s no secret that more money and less risk-averse investors are available in the US than in Europe. To keep innovati…
Join our 20.000 subscribers and receive the newsletter for free!
Upcoming events
Liquid biopsies & cancer
University Hall, Naamsestraat 22, Leuven
Mon 28 Aug 2017 - Wed 30 Aug 2017
28 Aug 08:30
- 30 Aug 17:00
The Leuven Cancer Institute (LKI) is happy to announce its upcoming symposium on "Liquid Biopsies & Cancer", on August 28-30, 2017 in Leuven (University Hall). The symposium is organised by th…
Vaccine Symposium
Brussels
Sat 09 Sep 2017
09:00
The FAMHP's VACCINS Excellence Center is organizing a Vaccinology Symposium on Saturday, September 9, 2017 at the Pullman Hotel (Brussels). This event is open to a wide audience: representativ…
Principles of Biosafety
UAntwerpen Stadscampus: Prinsstraat 13
2000 Antwerpen, Campus Mutsaard: Mutsaardstraat 31
2000 Antwerpen (11 & 14 Sept)
ITM: Nationalestraat 155, 2000 Antwerpen (12, 13 &15 Sept)
Mon 11 Sep 2017 - Fri 15 Sep 2017
11 Sep 08:30
- 15 Sep 17:00
A comprehensive course with lectures and practical demonstrations on biosafety and biorisk management.
